Sialylated glycoproteins and sialyltransferases in digestive cancers: mechanisms, diagnostic biomarkers, and therapeutic targets

SZ Zhang, A Lobo, PF Li, YF Zhang - Critical Reviews in Oncology …, 2024 - Elsevier
Sialic acid (SA), as the ultimate epitope of polysaccharides, can act as a cap at the end of
polysaccharide chains to prevent their overextension. Sialylation is the enzymatic process of …

[HTML][HTML] The vertebrate sialylation machinery: structure-function and molecular evolution of GT-29 sialyltransferases

A Harduin-Lepers - Glycoconjugate Journal, 2023 - Springer
Every eukaryotic cell is covered with a thick layer of complex carbohydrates with essential
roles in their social life. In Deuterostoma, sialic acids present at the outermost positions of …

ST6GAL1‐mediated aberrant sialylation promotes prostate cancer progression

E Scott, E Archer Goode, R Garnham… - The Journal of …, 2023 - Wiley Online Library
Aberrant glycosylation is a universal feature of cancer cells, and cancer‐associated glycans
have been detected in virtually every cancer type. A common change in tumour cell …

Bioorthogonal Chemical Labeling Probes Targeting Sialic Acid Isomers for N-Glycan MALDI Imaging Mass Spectrometry of Tissues, Cells, and Biofluids

X Lu, CT McDowell, CRK Blaschke, L Liu… - Analytical …, 2023 - ACS Publications
Sialic acid isomers attached in either α2, 3 or α2, 6 linkage to glycan termini confer distinct
chemical, biological, and pathological properties, but they cannot be distinguished by mass …

[HTML][HTML] Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics

KE Ankenbauer, TC Rao, AL Mattheyses… - Journal of Biological …, 2023 - ASBMB
Aberrant glycosylation is a hallmark of a cancer cell. One prevalent alteration is an
enrichment in α2, 6-linked sialylation of N-glycosylated proteins, a modification directed by …

[HTML][HTML] Sialylation: a cloak for tumors to trick the immune system in the microenvironment

X Zhou, K Chi, C Zhang, Q Liu, G Yang - Biology, 2023 - mdpi.com
Simple Summary Tumor cells accumulate sialylation in tissues via the coordination of
sialyltransferases and sialidases. Tumor sialylation can block receptor and ligand binding at …

[HTML][HTML] Cell Membrane Sialome: Sialic Acids as Therapeutic Targets and Regulators of Drug Resistance in Human Cancer Management

P Jastrząb, K Narejko, H Car, P Wielgat - Cancers, 2023 - mdpi.com
Simple Summary The aberrant sialylation of membrane glycocalyx plays a pivotal role in the
regulation of malignant cell behavior and correlates with a worse prognosis and shorter …

[HTML][HTML] Galectin-1 and galectin-3 in B-cell precursor acute lymphoblastic leukemia

F Fei, M Zhang, SS Tarighat, EJ Joo, L Yang… - International Journal of …, 2022 - mdpi.com
Acute lymphoblastic leukemias arising from the malignant transformation of B-cell
precursors (BCP-ALLs) are protected against chemotherapy by both intrinsic factors as well …

[HTML][HTML] Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone

K Hodgson, M Orozco-Moreno, EA Goode, M Fisher… - …, 2024 - thelancet.com
Background Bone metastasis is a common consequence of advanced prostate cancer.
Bisphosphonates can be used to manage symptoms, but there are currently no curative …

[HTML][HTML] Deficiency in ST6GAL1, one of the two α2, 6-sialyltransferases, has only a minor effect on the pathogenesis of prion disease

N Makarava, E Katorcha, JCY Chang… - Frontiers in Molecular …, 2022 - frontiersin.org
Prion diseases are a group of fatal neurodegenerative diseases caused by misfolding of the
normal cellular form of the prion protein or PrPC, into a disease-associated self-replicating …